A detailed history of Achmea Investment Management B.V. transactions in Johnson & Johnson stock. As of the latest transaction made, Achmea Investment Management B.V. holds 211,417 shares of JNJ stock, worth $32.7 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
211,417
Previous 219,746 3.79%
Holding current value
$32.7 Million
Previous $32.1 Million 6.68%
% of portfolio
0.57%
Previous 0.57%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $1.21 Million - $1.39 Million
-8,329 Reduced 3.79%
211,417 $34.3 Million
Q2 2024

Aug 08, 2024

BUY
$144.38 - $157.78 $2.36 Million - $2.58 Million
16,340 Added 8.03%
219,746 $32.1 Million
Q1 2024

May 08, 2024

SELL
$155.22 - $162.74 $246,334 - $258,268
-1,587 Reduced 0.77%
203,406 $32.2 Million
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $4.92 Million - $5.37 Million
-33,790 Reduced 14.15%
204,993 $32.1 Million
Q3 2023

Nov 06, 2023

SELL
$155.75 - $174.48 $4.02 Million - $4.5 Million
-25,788 Reduced 9.75%
238,783 $37.2 Million
Q2 2023

Jul 24, 2023

BUY
$154.35 - $166.11 $5.13 Million - $5.52 Million
33,204 Added 14.35%
264,571 $43.8 Million
Q1 2023

May 04, 2023

BUY
$151.05 - $180.26 $2.39 Million - $2.85 Million
15,806 Added 7.33%
231,367 $35.9 Million
Q4 2022

Feb 09, 2023

BUY
$160.2 - $179.79 $83,464 - $93,670
521 Added 0.24%
215,561 $35.7 Million
Q3 2022

Oct 27, 2022

SELL
$161.33 - $179.52 $2.12 Million - $2.36 Million
-13,141 Reduced 5.76%
215,040 $35.1 Million
Q2 2022

Aug 10, 2022

SELL
$168.19 - $186.01 $815,048 - $901,404
-4,846 Reduced 2.08%
228,181 $40.5 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $480,271 - $545,414
-3,037 Reduced 1.29%
233,027 $41.3 Million
Q4 2021

Feb 10, 2022

SELL
$155.93 - $173.01 $671,122 - $744,635
-4,304 Reduced 1.79%
236,064 $40.4 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $618,383 - $687,190
3,829 Added 1.62%
240,368 $38.8 Million
Q2 2021

Aug 06, 2021

SELL
$159.48 - $171.07 $435,220 - $466,850
-2,729 Reduced 1.14%
236,539 $39 Million
Q1 2021

May 11, 2021

SELL
$153.07 - $170.48 $1.34 Million - $1.49 Million
-8,724 Reduced 3.52%
239,268 $39.3 Million
Q4 2020

Feb 22, 2021

BUY
$137.11 - $157.38 $3 Million - $3.44 Million
21,867 Added 9.67%
247,992 $39 Million
Q3 2020

Nov 02, 2020

BUY
$140.38 - $153.83 $31.7 Million - $34.8 Million
226,125 New
226,125 $33.7 Million
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $21.7 Million - $30.1 Million
-195,230 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$127.5 - $146.44 $8.53 Million - $9.8 Million
-66,929 Reduced 25.53%
195,230 $28.5 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $5.27 Million - $5.9 Million
-41,519 Reduced 13.67%
262,159 $33.9 Million
Q2 2019

Aug 06, 2019

BUY
$131.15 - $144.24 $691,029 - $760,000
5,269 Added 1.77%
303,678 $42.3 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $6.71 Million - $7.46 Million
-53,346 Reduced 15.17%
298,409 $41.7 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $6.09 Million - $7.32 Million
49,543 Added 16.39%
351,755 $45.4 Million
Q3 2018

Nov 06, 2018

SELL
$121.58 - $142.88 $15.9 Million - $18.7 Million
-130,852 Reduced 30.22%
302,212 $41.8 Million
Q2 2018

Jul 27, 2018

SELL
$119.4 - $131.76 $7.22 Million - $7.97 Million
-60,470 Reduced 12.25%
433,064 $52.5 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $2.82 Million - $3.34 Million
22,513 Added 4.78%
493,534 $63.2 Million
Q4 2017

Feb 12, 2018

BUY
$131.22 - $143.62 $21.2 Million - $23.2 Million
161,702 Added 52.28%
471,021 $65.8 Million
Q3 2017

Nov 09, 2017

BUY
$129.47 - $135.38 $92,053 - $96,255
711 Added 0.23%
309,319 $40.2 Million
Q2 2017

Aug 29, 2017

BUY
N/A
308,608
308,608 $40.8 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Achmea Investment Management B.V. Portfolio

Follow Achmea Investment Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.